HR 9169 United States House · 119th Congress

PKD Cures Act

The PKD Cures Act directs the National Institutes of Health to expand and prioritize research into polycystic kidney disease, a common genetic condition that causes kidney failure in hundreds of thousands of Americans. To achieve this, the bill requires the NIH to intensify studies on the disease's genetic mechanisms, develop new treatments, and create a comprehensive research roadmap involving experts and patient advocates. This roadmap must outline strategies for collaboration, set timelines for innovation, and propose ways to integrate new technologies like artificial medicine into care. Additionally, the legislation mandates that the NIH establish a specialized working group to identify research gaps and submit a detailed report to Congress within 24 months.
Bill status in committee 1 of 4 stages cleared
Introduction
Jun 2026
Committee Review
Floor Vote
President
Introduced Jun 4, 2026 Last action Jun 4, 2026
Floor votes

How they voted

No floor votes recorded yet.
Full legislative history

Actions timeline

Total actions
2
Key actions
0
Committee
1
Jun 4, 2026
Committee
Referred to the House Committee on Energy and Commerce.
lower
Jun 4, 2026
Introduced
Introduced in House
lower
1 primary · 7 co-sponsors

Sponsors